Global News

[ad_1] NEW DELHI: Prime Minister Narendra Modi has said that India's economic growth is a “natural by-product” of his nine-year-old government's political stability, as he expressed optimism that it will be a developed nation by 2047 with "corruption, casteism and communalism" having no place in our national life. In an exclusive interview with PTI late last week, the prime minister also stressed on the need for timely and clear communication of policy stance by central banks, and policy actions by each country in their fight against inflation so that it can prevent negative repercussions on others countries. While most advanced economies are facing an economic slowdown, chronic shortages, high inflation, and ageing populations, the Indian economy is acknowledged to be the fastest-growing large economy with the largest youth population. "For a long time in world history, India was one of the top economies of the world. Later, due to the impact of colonisat

[ad_1] The newly FDA approved Alzheimer's treatment Leqembi is prepared at Abington Neurological Associates in Abington, PA., on Tuesday, November 7, 2023.  Hannah Yoon | The Washington Post | Getty Images The breakthrough Alzheimer's drug Leqembi slowed disease progression in patients over three years, demonstrating the need for them to stay on the treatment long term, according to new data released Tuesday by Japanese drugmaker Eisai .  The study results on Leqembi, which Eisai shares with Biogen , also found that a patient's Alzheimer's disease worsens after they stop treatment. Rates of adverse side effects associated with Leqembi, including brain bleeding and swelling, dropped after six months of treatment, Dr. Lynn Kramer, Eisai's chief clinical officer of deep human biology learning, told CNBC.  That decline is critical: Those side effects in the brain have raised concerns among some doctors and are the main reason a European drug regulator recommend

[ad_1] According to a recent study, patients who underwent an intermittent fasting diet intervention achieved complete diabetes remission. Fidn out more. [ad_2] Source link https://worldnews2023.com/health/zee-news-latest-news-live-breaking-news-today-news-india-political-news-updates/?feed_id=321615&_unique_id=67178729620b4

[ad_1] A nurse prepares a dose of Moderna Covid-19 vaccine at Oltepesi Dispensary in Kajiado, Kenya, on September 9, 2021. Patrick Meinhardt | AFP | Getty Images Moderna on Thursday said it has paused plans to build a vaccine-manufacturing site in Kenya after a steep drop in demand for its Covid vaccines . The biotech company said it has not received any vaccine orders for Africa since 2022 and has taken more than $1 billion in losses and write-downs related to the cancellation of previous orders from the continent. Moderna's decision aligns with its broader effort to cut costs by resizing its Covid vaccine-manufacturing footprint. The company's business took a major hit last year as demand for those jabs waned worldwide, with people relying less on protective vaccines and treatments against the virus. Shares of Moderna fell 45% last year, but the stock is up around 6% this year. In March 2022, the company said it would invest about $500 million in the Kenyan site and

[ad_1] Drone warfare in Bakhmut An Ukrainian serviceman attaches a hand grenade to use in an attack, near Bachmut, in the region of Donbas. An Ukrainian serviceman attaches a hand grenade on a drone to use in an attack, near Bachmut, in the region of Donbas, on March 15, 2023.  Aris Messinis | AFP | Getty Images An Ukrainian serviceman attaches a hand grenade on a drone to use in an attack, near Bachmut, in the region of Donbas, on March 15, 2023.  Aris Messinis | AFP | Getty Images — Aris Messinis | AFP | Getty Images Russia ambassador says Moscow will "no longer allow anyone to break into its waters" Russia's Ambassador to the U.S. Anatoly Antonov appeared to blame the U.S. for the downing of a U.S. drone over the Black Sea on Tuesday that the U.S. military blamed on the "reckless" and "unsafe" behavior of Russian fighter jets. Mark Wilson | Getty Images News | Getty Images Russia's Ambassador Anatoly Antonov said that Moscow will "no l

[ad_1] World Earth Day is an annual event celebrated on April 22nd to raise awareness about environmental issues and promote global efforts to protect the Earth's natural resources. The first Earth Day was celebrated in 1970, and since then it has become a global movement with millions of people participating in various events, activities and campaigns to show their support for environmental protection and sustainability. History The first World Earth Day was held on April 22, 1970, in the United States. It was organized by a group of environmental activists led by Senator Gaylord Nelson , who was concerned about the negative impact of industrialization and pollution on the environment. Senator Nelson wanted to create a national day of environmental education and awareness that would mobilize people across the country to take action to protect the planet. He chose April 22 as the date for the event because it fell between spring break and final exams, making it an ideal ti

[ad_1] Moscow's combat position in the war in Ukraine will not be impacted by the loss of troops belonging to Russian paramilitary group Wagner, according to a senior Russian defense official. Wagner forces were integral to Moscow's advance in Kyiv before the group staged an attempted insurrection at the end of last month, damaging relations with the Kremlin's top military brass irreconcilably. The failed rebellion propelled Wagner leader Yevgeny Prigozhin into exile in Belarus and the militia group said it has now suspended recruitment as it relocates to the country. Members of Wagner group looks from a military vehicle in Rostov-on-Don late on June 24, 2023.  Roman Romokhov | AFP | Getty Images Elsewhere, a new center for the prosecution of aggression in Ukraine opens on Monday, bolstering the capabilities of the Dutch-based International Criminal Court, which is limited in its mandate to pursue crimes of aggression. The ICC already has open warrants for Russian Pres

[ad_1] A messy legal fight over the Food and Drug Administration's approval of the abortion pill mifepristone poses risks to the biopharma industry that go beyond the single drug. If a subsequent decision tosses out the pill's approval, it could potentially stifle innovation in the sector and deter investments in the development of life-changing drugs, biopharma companies and experts in law and economics say.  related investing news The ruling Friday by U.S. District Judge Matthew Kacsmaryk of Amarillo, Texas, appears to be the first time a court has suspended the FDA's approval of a medication. The 5th U.S. Circuit Court of Appeals late Wednesday partly granted the Biden administration's request to put the order on hold, making mifepristone available for now but with significant restrictions .  The Justice Department will seek emergency intervention from the U.S. Supreme Court, it said Thursday. Nationwide access to mifepristone still hangs in the balance as the

[ad_1] A GSK lab in London. Oli Scarff | Getty Images The Food and Drug Administration on Wednesday approved an RSV vaccine produced by GlaxoSmithKline for use on adults ages 60 and older. The approval, the first ever globally by a regulatory body for an RSV vaccine , is a decisive victory for GSK in a race against drugmakers Pfizer and Moderna to bring to market a shot that targets the respiratory syncytial virus . Shares of GSK rose nearly 2% Wednesday following the approval. GSK's chief scientific officer Tony Wood said in a statement the decision "marks a turning point" in the company's effort to reduce the "significant burden" of RSV. The company will now focus on ensuring eligible older adults in the U.S. can access the vaccine "as quickly as possible," he said. GSK will also work toward regulatory review and approval of the shot in other countries. London-based GSK during an earnings presentation last week said it has "mil

[ad_1] Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020.  Mike Blake | Reuters Eli Lilly on Tuesday reported first-quarter adjusted profit that topped Wall Street's expectations and hiked its full-year guidance on strong sales of its blockbuster diabetes drug Mounjaro and newly launched weight loss treatment Zepbound. The drugmaker now expects full-year adjusted earnings of $13.50 to $14.00 per share, up from previous guidance of $12.20 to $12.70 per share. Eli Lilly also expects revenue for the year to come in between $42.4 billion and $43.6 billion, an increase of $2 billion at either end of the range. Analysts surveyed by LSEG expected full-year adjusted earnings of $12.50 per share and sales of $41.44 billion.  The company said the boosted guidance is in part due to optimism around increased production of Zepbound, Mounjaro and similar drugs for the rest of the year. "Now that we're four months into th